Directori de persones
Farida Dakterzada Sedaghat

Farida Dakterzada Sedaghat

Grau: Doctor/a

973702413
fdakterzada(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/G-4155-2016

Grups

Publicacions

  • Dakterzada, F; Cipriani, R; López-Ortega, R; Arias, A; Riba-Llena, I; Ruiz-Julián, M; Huerto, R; Tahan, N; Matute, C; Capetillo-Zarate, E; Piñol-Ripoll, G

    Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 25 -. .

    [doi:10.3390/ijms25094594]

  • Dakterzada, F; Jové, M; Cantero, JL; Mota-Martorell, N; Pamplona, R; Piñoll-Ripoll, G

    The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease

    ALZHEIMERS & DEMENTIA 20 3322-3333. .

    [doi:10.1002/alz.13792]

  • Dakterzada, F; Jové, M; Huerto, R; Carnes, A; Sol, J; Pamplona, R; Piñol-Ripoll, G

    Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer's disease

    Geroscience 46 683-696. .

    [doi:10.1007/s11357-023-00989-x]

  • Dakterzada, F; Benitez, ID; Targa, A; Carnes, A; Pujol, M; Jove, M; Minguez, O; Vaca, R; Sanchez-de-la-Torre, M; Barbe, F; Pamplona, R; Pinol-Ripoll, G

    Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimers Research & Therapy 15 134-134. .

    [doi:10.1186/s13195-023-01278-7]

  • Targa, ADS; Benitez, ID; Moncusi-Moix, A; Dakterzada, F; Minguez, O; Vaca, R; Dalmases, M; Sanchez-de-la-Torre, M; Barbe, F; Pinol-Ripoll, G

    Breathing cessation events that compose the apnea-hypopnea index are distinctively associated with the adverse outcomes in Alzheimer's disease

    Alzheimers Research & Therapy 15 123-123. .

    [doi:10.1186/s13195-023-01266-x]

  • Dakterzada, F; Jove, M; Huerto, R; Carnes, A; Sol, J; Pamplona, R; Piñol-Ripoll G

    Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer's Disease.

    Aging and Disease 14 1728-1738. .

    [doi:10.14336/AD.2023.0221]

  • Dakterzada F; Jové M; Cantero JL; Pamplona R; Piñoll-Ripoll G

    Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease.

    Redox Biology 64 102772-102772. .

    [doi:10.1016/j.redox.2023.102772]

  • Dakterzada, Farida; Benitez, Ivan D.; Targa, Adriano; Carnes, Anna; Pujol, Montse; Jove, Mariona; Minguez, Olga; Vaca, Rafi; Sanchez-de-la-Torre, Manuel; Barbe, Ferran; Pamplona, Reinald; Piñol-Ripoll G

    Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer's disease.

    Alzheimers Research & Therapy 14 163-163. .

    [doi:10.1186/s13195-022-01102-8]

  • Vazquez-Justes, D; Aguirregoicoa, I; Fernandez, L; Carnes-Vendrell, A; Dakterzada, F; Sanjuan, L; Mena, A; Piñol-Ripoll G

    Clinical impact of microbleeds in patients with Alzheimer's disease.

    BMC Geriatrics 22 774-774. .

    [doi:10.1186/s12877-022-03456-y]

  • Torres-Bondia F; Dakterzada F; Galván L; Buti M; Besanson G; Grill E; Buil R; de Batlle J; Piñol-Ripoll G

    Benzodiazepine and Z-drug use and the risk of developing dementia.

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 25 261-268. .

    [doi:10.1093/ijnp/pyab073]

  • Targa ADS; Benítez ID; Dakterzada F; Carnes A; Pujol M; Jorge C; Minguez O; Dalmases M; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G

    Sleep profile predicts the cognitive decline of mild-moderate Alzheimer's disease patients.

    Sleep 44 -. .

    [doi:10.1093/sleep/zsab117]

  • Targa ADS; Benítez ID; Dakterzada F; Fontenele-Araujo J; Minguez O; Zetterberg H; Blennow K; Barbé F; Piñol-Ripoll G

    The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer's disease patients.

    Alzheimers Research & Therapy 13 161-161. .

    [doi:10.1186/s13195-021-00903-7]

Projectes

  • Insight into the role of lipids in frontotemporal dementia: uncovering pathophysiological alterations and biomarker discovery opportunities.
  • Development of dynamic models for the personalized prevention and treatment of age-related diseases
  • Importancia del sueño y los ritmos circadianos en la biología y evolución clínica de los sujetos en el continuum de la Enfermedad de Alzheimer.
  • Ajuts per a la contractació de personal investigador novell (FI-2019)
  • Biomarcadores lipidómicos de la progresión de la enfermedad de Alzheimer en pacientes con deterioro cognitivo leve
  • Programes de recerca: estudi de biomarcadors i desenvolupament de noves estratègies terapèutiques en una cohort multicèntrica de Demència Frontotemporal